King Pharmaceuticals KG Reinsurance recoverable on unpaid losses and loss expenses
Reinsurance recoverable on unpaid losses and loss expenses at other companies
Segments
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's reinsurance recoverable on unpaid losses and loss expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's reinsurance recoverable on unpaid losses and loss expenses?
- King Pharmaceuticals (KG) reported reinsurance recoverable on unpaid losses and loss expenses of $436.38M in Q1 2026.
- What does reinsurance recoverable on unpaid losses and loss expenses mean?
- This represents the portion of unpaid insurance claims and loss adjustment expenses that the company expects to recover from reinsurers. It reflects the company's reliance on third-party risk transfer mechanisms to mitigate large loss exposures. Investors analyze this to evaluate the credit risk associated with the company's reinsurance counterparties.